CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
October 8th 2019
An ovarian cancer survivor shares what she wishes she had known then with those who are newly diagnosed.
October 4th 2019
Knowing your family history is the first preventative step any woman can take to avoid a diagnosis of ovarian cancer.
October 2nd 2019
"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."
October 1st 2019
CURE spoke with an expert on how patients can better advocate for themselves when it comes to genetic testing and its follow-up.
September 30th 2019
Ovarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.
September 29th 2019
Frontline maintenance therapy with Zejula lengthened time without disease progression among women with newly diagnosed, advanced ovarian cancer, according to findings from the phase 3 PRIMA study.
September 28th 2019
The addition of Lynparza to maintenance therapy with Avastin improved time to disease progression in women with advanced ovarian cancer, according results of the PAOLA-1/ENGOT-ov25 trial.
September 24th 2019
CURE spoke with an expert from Mount Sinai to discuss the future of ovarian cancer treatment and his advice for women facing a new diagnosis.
September 16th 2019
“For so long ovarian cancer has been a secret part of my life. That’s over now.”
September 11th 2019
"I’m a work in progress. I work to heed my oncologist’s advice: Don’t spoil today by worrying about tomorrow."
September 3rd 2019
A rare type of ovarian tumor can raise testosterone levels, causing women to develop male characteristics. The main treatments: surgery and chemotherapy.
September 3rd 2019
September is Ovarian Cancer Awareness Month. Here’s a round-up of the latest news and updates in this disease space.
August 30th 2019
From a return to work for Alex Trebek to a personalized Backstreet Boys concert, here’s what is making headlines in the cancer space this week.
August 27th 2019
The US Preventive Services Task Force now recommends for genetic counseling and testing for survivors of certain cancer types, but many at high-risk for the disease are left off the list.
August 21st 2019
In a new study, Zejula (niraparib) has been shown to prolong life for patients with ovarian cancer who have already undergone four or more rounds of chemotherapy.
August 19th 2019
Removing lymph nodes that appear unaffected by ovarian cancer won’t help and might hurt.
August 13th 2019
A recent study found that only a quarter of women with breast cancer and a third of women with ovarian cancer had undergone genetic testing. Memorial Sloan Kettering experts say these numbers are surprisingly low.
July 31st 2019
One survivor shares how the support of the Cancer Institute at St. Francis and oncology nurse Rose Francucci helped her embrace her cancer journey with positivity.
July 30th 2019
While recovering from ovarian cancer and chemotherapy, I got it into my head that I needed a garden space. My garden represents not only my physical labor, but also my focus, which is on the future.
July 18th 2019
By going public with the details of their cancer journeys, patients and survivors can pave the way for understanding and support.
July 9th 2019
While half of women with gynecologic cancer reported experiencing significant fatigue during treatment, only 8% of survivors had symptoms regress without intervention.
June 25th 2019
The FDA has granted a priority review designation to a supplemental biologics license application for Zejula for the treatment of certain patients with advanced ovarian, fallopian tube or primary peritoneal cancer.
June 12th 2019
Sue Friedman, founder and executive director of FORCE, discussed how a breast cancer diagnosis at age 33 and a family history of cancer led to the creation of Facing Our Risk of Cancer Empowered.
May 30th 2019
Patients with ovarian cancer who experience disease recurrences can have potentially helpful options from a large array of drugs, each of which can bring on side effects. Luckily, doctors have a variety of ways to relieve or prevent these discomforts. At the same time, scientists are working to develop new treatments that may be both efficacious and easier for patients to tolerate.